News and press releases
Stay up to date with the Association’s news and events.
Quick links
Press Releases
PPTA Statements
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Apr 17, 2014
PPTA Recognizes World Hemophilia Day 2014
April 17, 2014–The Plasma Protein Therapeutics Association (PPTA) recognizes World Hemophilia Day, an annual international event sponsored by the World Federation for Hemophilia (WFH) that seeks to raise awareness of people living with inherited bleeding disorders.
All
Press releases
Apr 17, 2014
PPTA Recognizes World Hemophilia Day 2014
April 17, 2014–The Plasma Protein Therapeutics Association (PPTA) recognizes World Hemophilia Day, an annual international event sponsored by the World Federation for Hemophilia (WFH) that seeks to raise awareness of people living with inherited bleeding disorders.
All
Press releases
Apr 14, 2014
PPTA Recognizes First Plasma Collection Centers Certified in Hungary
ANNAPOLIS, MD—The Plasma Protein Therapeutics Association (PPTA) has awarded Plazmaferezis Állomás Kft (PFÁ), a member operating within the Kedrion group of companies, with International Quality Plasma Program (IQPP) certification for its plasma collection centers in Hungary; two in Budapest and one in Debrecen.
All
Press releases
Apr 14, 2014
PPTA Recognizes First Plasma Collection Centers Certified in Hungary
ANNAPOLIS, MD—The Plasma Protein Therapeutics Association (PPTA) has awarded Plazmaferezis Állomás Kft (PFÁ), a member operating within the Kedrion group of companies, with International Quality Plasma Program (IQPP) certification for its plasma collection centers in Hungary; two in Budapest and one in Debrecen.
All
Press releases
Mar 23, 2010
Human Parvovirus PARV4 and plasma protein therapies
Parvoviruses are small, non-enveloped DNA viruses that infect both vertebrate and invertebrate hosts. The human Parvovirus PARV4 has first been described in 2005 by Jones et al. For PARV4 no associated disease or specific symptoms have been observed.
All
PPTA statements
Mar 23, 2010
Human Parvovirus PARV4 and plasma protein therapies
Parvoviruses are small, non-enveloped DNA viruses that infect both vertebrate and invertebrate hosts. The human Parvovirus PARV4 has first been described in 2005 by Jones et al. For PARV4 no associated disease or specific symptoms have been observed.
All
PPTA statements
Apr 28, 2009
Statement on the Safety of Plasma Protein Therapies and Swine Influenza Virus
PPTA member companies are committed to providing safe and effective therapies and PPTA understands that patients who rely on these often life-saving therapies may have concerns about the possible transmission of Swine Influenza Virus through them in view of the recent outbreak in humans. Therapies produced by PPTA members remain safe and available.
All
PPTA statements
Apr 28, 2009
Statement on the Safety of Plasma Protein Therapies and Swine Influenza Virus
PPTA member companies are committed to providing safe and effective therapies and PPTA understands that patients who rely on these often life-saving therapies may have concerns about the possible transmission of Swine Influenza Virus through them in view of the recent outbreak in humans. Therapies produced by PPTA members remain safe and available.
All
PPTA statements
No results found